Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market
Holding ARQT?
Track your performance easily

Arcutis Biotherapeutics (ARQT) Ownership - Who Owns Arcutis Biotherapeutics?

716 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 03, 2024
Larry Todd Edwards
Svp Chief Commercial Officer
xxxxxxxxxxxxx
$37287
Sep 25, 2024
xxxxxxxxxxxxx
$110214
Aug 21, 2024
Patrick Burnett
Reporting Person's Title: Svp And Chief Medical Officer
xxxxxxxxxxxxx
$14308
Jul 02, 2024
xxxxxxxxxxxxx
$93100

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,601,723Institution4.79%56,129,264
4,916,035Institution4.21%49,258,671
4,511,886Institution3.86%45,209,098
3,725,459Institution3.19%37,329,099
3,616,532Institution3.09%36,237,651
3,220,395Institution2.76%32,268,358
3,085,198Institution2.64%30,913,684
2,735,010Institution2.34%27,404,800
1,883,945Institution1.61%18,877,129
1,766,984Institution1.51%17,705,180

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,511,886Institution3.86%45,209,098
3,725,459Institution3.19%37,329,099
3,085,198Institution2.64%30,913,684
2,735,010Institution2.34%27,404,800
1,883,945Institution1.61%18,877,129
1,766,984Institution1.51%17,705,180
1,439,616Institution1.23%14,424,952
1,215,430Institution1.04%12,178,609
1,173,874Institution1.00%11,762,217
1,072,979Institution0.92%10,751,250

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,097,410Institution2.65%33,699,821
3,070,330Institution2.63%30,764,707
2,735,763Institution2.34%27,836,389
1,583,799Institution1.35%17,231,733
945,455Institution0.81%9,620,005
738,888Institution0.63%7,403,658
504,433Institution0.43%5,054,419
429,719Institution0.37%4,675,343
443,042Institution0.38%4,507,952
443,042Institution0.38%4,507,952

FAQ

Who Owns Arcutis Biotherapeutics (ARQT)?
Currently, no data Available
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors?
Currently, no data Available
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Arcutis Biotherapeutics (ARQT)?
Vanguard owns the most shares of Arcutis Biotherapeutics (ARQT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis